PAPZIMEOS

This brand name is authorized in United States.

Active ingredients

The drug PAPZIMEOS contains one active pharmaceutical ingredient (API):

1
UNII C525BYS7TP - ZOPAPOGENE IMADENOVEC
 

Ζopapogene imadenovec is a non-replicating adenoviral vector-based immunotherapy designed to express a fusion antigen of selected regions of human papillomavirus (HPV) proteins expressed in HPV 6- and HPV 11-infected cells. Ζopapogene imadenovec is designed to generate an immune response directed against HPV 6 and HPV 11 proteins in patients with recurrent respiratory papillomatosis.
 
Read more about Ζopapogene imadenovec

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 PAPZIMEOS Suspension for injection MPI, US: SPL/PLR FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
US FDA, National Drug Code 84768-511

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈